Patients with: • refractory disabling headache of any type; • cluster headache and other trigeminal autonomic cephalalgias, at first presentation; • MOH involving drugs of dependence, where personality mitigates against successful withdrawal of medication, or where withdrawal attempts have failed; • high and low CSF-pressure headaches; • trigeminal and other cranial neuralgias or painful lesions of the cranial nerves; • rare primary or secondary headaches; • headaches with severe physical and/or psychological comorbidities. Cases: • of persisting diagnostic uncertainty; • where risk of serious underlying disorders demands specialist investigation; • of other probable or certain serious secondary headache. Patients who may participate in specific level-3 research projects (including clinical trials). |